Bain Capital GSS Investment Corp. (BCSS): Total Liabilities

Annual figures by period end, from SEC filings.

$16.39M

As of 2025-12-31

$16.76M

As of 2026-06-30

Period ended	Total Liabilities	Change YoY	Source filing
2025-12-31	$16.39M	n/a	2026-03-20, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Blank Checks), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Total Liabilities	Change YoY
Bain Capital GSS Investment Corp. (BCSS)	2025-12-31	$16.39M	n/a
EQV Ventures Acquisition Corp. II (EVAC)	2025-12-31	$18.13M	n/m
Cantor Equity Partners IV, Inc. (CEPF)	2025-12-31	$95.4K	n/m
Drugs Made In America Acquisition II Corp. (DMII)	2025-12-31	$17.80M	n/m
Gores Holdings X, Inc. (GTEN)	2025-12-31	$32.38M	n/m
Innventure, Inc. (INV)	2025-12-31	$115.51M	-16.9%
Rice Acquisition Corp 3 (KRSP)	2025-12-31	$16.10M	n/a
M3-Brigade Acquisition VI Corp. (MBVI)	2025-12-31	$16.71M	n/a
American Exceptionalism Acquisition Corp. A (AEXA)	2025-12-31	$20.80M	n/a

Compare BCSS, EVAC, CEPF, DMII side by side · Screen every company in Blank Checks ↗